8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [Rytary]
- RxCUI
- 1600917
- RxNorm name
- 8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [Rytary]
- Display name
- 8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [Rytary]
- Full name
- 8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [Rytary]
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RYTARY | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 2026-03-26 | Warnings, Adverse reactions | 1600917 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 8 HR Carbidopa 61.25 MG / L-DOPA 245 MG Extended Release Oral Capsule [Rytary] | SY | 26 | These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975 | 20260326 |
| 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 8 HR carbidopa 61.25 MG / levodopa 245 MG Extended Release Oral Capsule [Rytary] | SBD | 26 | These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975 | 20260326 |
| 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | Rytary (carbidopa 61.25 MG / levodopa 245 MG) 8 HR Extended Release Oral Capsule | SY | 26 | These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975 | 20260326 |
| 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | RYTARY 61.25 MG / 245 MG 8HR Extended Release Oral Capsule | PSN | 26 | These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975 | 20260326 |